p21 induces a senescence program and skeletal muscle dysfunction.

p21 induces a senescence program and skeletal muscle dysfunction.
复制标题

DOI:
10.1016/j.molmet.2022.101652
复制
发表时间:
2023-01
影响因子:
8.1
通讯作者:
LeBrasseur, Nathan K.
LeBrasseur, Nathan K.
中科院分区:
医学1区
文献类型:
--
作者:
Englund, Davis A.;Jolliffe, Alyssa;Aversa, Zaira;Zhang, Xu;Sturmlechner, Ines;Sakamoto, Ayumi E.;Zeidler, Julianna D.;Warner, Gina M.;McNinch, Colton;White, Thomas A.;Chini, Eduardo N.;Baker, Darren J.;van Deursen, Jan M.;LeBrasseur, Nathan K.

文献摘要

参考文献

被引文献

相似文献

最近的工作已经建立了小鼠和人类p21升高,衰老细胞积累和骨骼肌功能障碍之间的关联。使用p21过表达的小鼠模型(p21OE),我们研究了p21是否在骨骼肌细胞衰老和病理特征中起作用。我们发现,p21诱导骨骼肌细胞衰老的几个核心特性,包括改变转录组,DNA损伤,线粒体功能障碍和衰老相关的分泌表型(SASP)。此外,与年龄匹配的对照组相比,p21 OE小鼠表现出骨骼肌病理学的表现,如萎缩、纤维化和身体功能受损。这些发现表明,p21本身就足以驱动细胞衰老程序,并揭示了骨骼肌损失和功能障碍的新来源。p21在骨骼肌中诱导与衰老程序一致的转录程序。p21诱导骨骼肌衰老的核心特性,包括DNA损伤、线粒体功能障碍和SASP。过表达p21的小鼠表现出肌肉病理学的迹象,如萎缩、纤维化和身体功能受损。
Recent work has established associations between elevated p21, the accumulation of senescent cells, and skeletal muscle dysfunction in mice and humans. Using a mouse model of p21 overexpression (p21OE), we examined if p21 mechanistically contributes to cellular senescence and pathological features in skeletal muscle. We show that p21 induces several core properties of cellular senescence in skeletal muscle, including an altered transcriptome, DNA damage, mitochondrial dysfunction, and the senescence-associated secretory phenotype (SASP). Furthermore, p21OE mice exhibit manifestations of skeletal muscle pathology, such as atrophy, fibrosis, and impaired physical function when compared to age-matched controls. These findings suggest p21 alone is sufficient to drive a cellular senescence program and reveal a novel source of skeletal muscle loss and dysfunction. p21 induces a transcriptional program in skeletal muscle consistent with a senescence program. p21 induces core properties of senescence in skeletal muscle, including DNA damage, mitochondrial dysfunction, and the SASP. Mice that overexpress p21 exhibit signs of muscle pathology, such as atrophy, fibrosis, and impaired physical function.
DOI: 10.2337/db15-0291
发表时间: 2016-06
期刊: Diabetes
影响因子: 7.7
作者:
Schafer MJ;White TA;Evans G;Tonne JM;Verzosa GC;Stout MB;Mazula DL;Palmer AK;Baker DJ;Jensen MD;Torbenson MS;Miller JD;Ikeda Y;Tchkonia T;van Deursen JM;Kirkland JL;LeBrasseur NK
通讯作者: LeBrasseur NK
抗萎缩与萎缩易感的骨骼肌:“ Aras”是一种新型的实验范式,以研究人类废物萎缩的机制。
DOI: 10.3389/fphys.2021.653060
发表时间: 2021
影响因子: 4
作者:
Bass JJ;Hardy EJO;Inns TB;Wilkinson DJ;Piasecki M;Morris RH;Spicer A;Sale C;Smith K;Atherton PJ;Phillips BE
通讯作者: Phillips BE
DOI: 10.1093/function/zqaa033
发表时间: 2021
期刊: Function (Oxford, England)
影响因子: --
作者:
Englund DA;Figueiredo VC;Dungan CM;Murach KA;Peck BD;Petrosino JM;Brightwell CR;Dupont AM;Neal AC;Fry CS;Accornero F;McCarthy JJ;Peterson CA
通讯作者: Peterson CA
DOI: 10.1038/nature16932
发表时间: 2016-02-11
期刊: Nature
影响因子: 64.8
作者:
Baker DJ;Childs BG;Durik M;Wijers ME;Sieben CJ;Zhong J;Saltness RA;Jeganathan KB;Verzosa GC;Pezeshki A;Khazaie K;Miller JD;van Deursen JM
通讯作者: van Deursen JM
DOI: 10.1038/nature13013
发表时间: 2014-02-20
期刊: NATURE
影响因子: 64.8
作者:
Sousa-Victor, Pedro;Gutarra, Susana;Munoz-Canoves, Pura
通讯作者: Munoz-Canoves, Pura